News
Browse all news articles and resources.
2
articles
News4 min readQuick Read
New PTSD Prevention Drug Trial Enrolls First Patients
A DoD-backed Phase 2a trial is testing BXCL501 for acute stress reactions and PTSD prevention. Here's what ketamine patients should understand.
News5 min readStandard
BPL-003 Shows Lasting Relief in Treatment-Resistant Depression
New phase 2a data on BPL-003 shows sustained symptom reduction in treatment-resistant depression. What patients should know about this emerging therapy.